Norbert W. Bischofberger's most recent trade in Kronos Bio Inc was a trade of 10,802,138 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kronos Bio Inc | Norbert W. Bischofberger | Director, Ten Percent Owner | 20 Jun 2025 | 10,802,138 | 0 | - | 0.6 | 6,157,219 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 699,800 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 570,868 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 400,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 297,186 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, Ten Percent Owner | 20 Jun 2025 | 263,750 | 0 | - | 0.6 | 150,338 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, Ten Percent Owner | 20 Jun 2025 | 263,750 | 0 | - | 0.6 | 150,338 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, Ten Percent Owner | 20 Jun 2025 | 263,750 | 0 | - | 0.6 | 150,338 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, Ten Percent Owner | 20 Jun 2025 | 263,750 | 0 | - | 0.6 | 150,338 | Common Stock | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Other type of transaction at price $ 0.00 per share. | 06 Jun 2025 | 10,667 | 10,667 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Other type of transaction at price $ 0.00 per share. | 06 Jun 2025 | 10,667 | 13,333 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 8,000 | 24,000 (0%) | 0% | 0 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | 27 Jun 2024 | 410,848 | 10,597,468 | - | 1.2 | 478,843 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | 27 Jun 2024 | 204,670 | 10,802,138 | - | 1.2 | 254,957 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | 10 Jun 2024 | 1,378,901 | 5,749,395 | - | 0.9 | 1,208,469 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | 10 Jun 2024 | 881,913 | 7,375,616 | - | 1.2 | 1,096,041 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | 10 Jun 2024 | 744,308 | 6,493,703 | - | 1.1 | 814,571 | Common Stock | |
| Morphic Holding Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,168 | 23,168 | - | - | Common Stock | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 16,000 | 16,000 (0%) | 0% | 0 | Common Stock | |
| Kronos Bio Inc | W. Norbert Bischofberger | Director, PRESIDENT & CEO | 15 Feb 2024 | 699,800 | 699,800 | - | - | Employee Stock Option (Right to Buy) | ||
| Kronos Bio Inc | W. Norbert Bischofberger | Director, PRESIDENT & CEO | 15 Feb 2024 | 270,339 | 2,811,004 | - | 0 | Common Stock | ||
| Morphic Holding Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,535 | 12,535 | - | - | Director Stock Option (Right to Buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 15 Feb 2023 | 570,868 | 570,868 | - | - | Employee Stock Option (Right to Buy) | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 17 May 2022 | 300,000 | 809,609 | - | 3.8 | 1,134,510 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 17 May 2022 | 206,198 | 509,609 | - | 3.7 | 768,046 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 17 May 2022 | 90,931 | 303,411 | - | 3.8 | 348,529 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 16 Feb 2022 | 400,000 | 400,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 06 Dec 2021 | 14,356 | 212,480 | - | 12.1 | 173,492 | Common Stock | |
| Morphic Holding Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 12,000 | 12,000 | - | - | Director Stock Option (right to buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 10 Dec 2020 | 297,186 | 297,186 | - | - | Employee Stock Option (Right to Buy) | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 10 Dec 2020 | 198,124 | 198,124 | - | 0 | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 1,651,576 | 4,089,238 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 1,565,475 | 0 | - | - | Series A Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 316,501 | 2,437,662 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 300,001 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 263,750 | 263,750 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 263,750 | 263,750 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 263,750 | 263,750 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 263,750 | 263,750 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 250,000 | 0 | - | - | Series Seed Preferred | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 250,000 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 250,000 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 250,000 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 185,758 | 4,274,996 | - | 16.2 | 2,999,992 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 95,500 | 4,370,496 | - | 19 | 1,814,500 | Common Stock |